« Back
Home /
Thalidomide-PEG2-C2-NH2 (TFA)

Thalidomide-PEG2-C2-NH2 (TFA)

Item no.	CS-0112179-1mg
Manufacturer	ChemScene
Amount	1mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	2097509-36-7
Similar products	2097509-36-7
Available
Alternative Names	Thalidomide-NH-PEG2-C2-NH2 (TFA)
CAS	2097509-36-7
Purity	>98%
MWt	518.44
Formula	C21H25F3N4O8
Solubility	10 mM in DMSO
Clinical Information	No Development Reported
Pathway	PROTAC
Target	E3 Ligase Ligand-Linker Conjugate
Biological Activity	Thalidomide-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology^[1]. In Vitro: PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
Research Area	Cancer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

available

Delivery expected until 7/3/2025

Express Delivery: Save 16 days

Compare

Add to wishlist

Recommend by mail